2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …

E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

[HTML][HTML] State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation

M Casali, C Lauri, C Altini, F Bertagna… - Clinical and …, 2021 - Springer
Aim The diagnosis, severity and extent of a sterile inflammation or a septic infection could be
challenging since there is not one single test able to achieve an accurate diagnosis. The …

ERS clinical practice guidelines on treatment of sarcoidosis

RP Baughman, D Valeyre, P Korsten… - European …, 2021 - Eur Respiratory Soc
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …

[HTML][HTML] Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular …

RHJA Slart, AWJM Glaudemans, O Gheysens… - European journal of …, 2021 - Springer
With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in
cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with …

[HTML][HTML] EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging

R Sciagrà, M Lubberink, F Hyafil, A Saraste… - European Journal of …, 2021 - Springer
The use of cardiac PET, and in particular of quantitative myocardial perfusion PET, has been
growing during the last years, because scanners are becoming widely available and …

Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

J Lehtonen, V Uusitalo, P Pöyhönen… - European Heart …, 2023 - academic.oup.com
Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging

S Mavrogeni, A Pepe, R Nijveldt, N Ntusi… - European Heart …, 2022 - academic.oup.com
Autoimmune rheumatic diseases (ARDs) involve multiple organs including the heart and
vasculature. Despite novel treatments, patients with ARDs still experience a reduced life …

Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review

NA Gilotra, JM Griffin, N Pavlovic, BA Houston… - Journal of cardiac …, 2022 - Elsevier
The prevalence of sarcoidosis-related cardiomyopathy is increasing. Sarcoidosis impacts
cardiac function through granulomatous infiltration of the heart, resulting in conduction …

Hybrid cardiac magnetic resonance/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis

S Greulich, S Gatidis, C Gräni, R Blankstein… - Cardiovascular …, 2022 - jacc.org
Objectives The purpose of this study was to investigate the diagnostic value of simultaneous
hybrid cardiac magnetic resonance (CMR) and 18F-fluorodeoxyglucose positron emission …

[HTML][HTML] Diagnostic Performance of 18F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses

G Treglia - Contrast media & molecular imaging, 2019 - hindawi.com
Purpose. To date, several meta-analyses have reported data about the diagnostic
performance of 18 F-FDG PET/CT in infectious and inflammatory diseases. This article aims …